Products

THE END

Write your next screenplay here.

theendscript.com Writing & Documents / Fiction & Script Writing

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$3.99/mo
Lower than 91% of peersNiche median $9.99/mo
Creators
CIBELE, Inc.
No social account linked
Launched
3mo ago
2026-08-18 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Write, store and share screenplays securely in the cloud

    Aug 18 · 3mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-07-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: New accounts start with a 3-day free trial. · Observed 2026-11-06 · Source page

Entry price $3.99/mo, Lower than 91% of peers; “Fiction & Script Writing” median is $9.99/mo.View pricing benchmark

Pages & changes

Tracked since 2026-08-18

Key pages

Weekly snapshots
Home
theendscript.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does THE END cost?
The catalog records a monthly entry price of $3.99. Plan details and current billing terms are not yet available.
How much website traffic does THE END get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is THE END and what platforms does it support?
THE END is catalogued under Fiction & Script Writing: Write your next screenplay here. Supported platforms: Web.

Related products in this category

Writing & Documents / Fiction & Script Writing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.